Disrupted Cholesterol Homeostasis as a Mechanism of Pharmaceutical-Induced Neurodevelopmental Toxicity: A Transgenic Zebrafish Screening Model for abcg1
Environmental Science & Technology · 2025
DOI: 10.1021/acs.est.5c04496 ↗At a glance
Journal article in Environmental Science & Technology, 2025. Written by Xinli Zhou and 11 co-authors. Institution: Department of Obstetric, Zhongnan Hospital of Wuhan University, School of Pharmaceutical Sciences, Wuhan University, Wuhan 430071, China. Major MEDLINE topics: Cholesterol, ATP Binding Cassette Transporter, Subfamily G, Member 1. Cited 1 times so far (Crossref); 54 references. Funded by: National Key Research and Development Program of China, National Natural Science Foundation of China.
Abstract (original language)
With the acceleration of industrialization, increased pharmaceutical consumption, and improper disposal of medications, the accumulation of pharmaceutical residues in the environment has become a global concern, posing significant threats to the neurodevelopment of embryos. Using zebrafish as a model organism, this study evaluated the neurodevelopmental toxicity of prednisone, dexamethasone, acetaminophen, amoxicillin, and azithromycin. The results demonstrated that these pharmaceuticals significantly inhibited embryo hatching, increased mortality, and induced abnormal neurobehavior during the critical developmental window of 36-72 h postfertilization. These effects were accompanied by reduced neuronal cholesterol levels, downregulated neurodevelopmental gene expression, and disrupted cholesterol metabolism. Mechanistic studies revealed that the downregulation of the cholesterol efflux transporter abcg1 is a key factor in pharmaceuticals-induced neurotoxicity. Suppression of abcg1 caused cholesterol accumulation in astrocytes and a deficiency in neurons, resulting in impaired neuronal function and structure. Conversely, overexpression of abcg1 alleviated these toxic effects. Furthermore, a transgenic zebrafish line, Tg(abcg1: EGFP), was developed to enable real-time visualization of abcg1 expression and demonstrated high sensitivity and specificity in detecting neurotoxicants. This study provides a novel tool and perspective for the neurotoxicity assessment of environmental pharmaceuticals.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Obstetric, Zhongnan Hospital of Wuhan University, School of Pharmaceutical Sciences, Wuhan University, Wuhan 430071, China.
- Department of Pharmacology, Taikang Medical School (School of Basic Medical Sciences), Wuhan university, Wuhan 430071, China.
- Hubei Provincial Key Laboratory of Developmentally Originated Disease, Wuhan 430071, China.
ORCID profiles: Dan Xu
Funding
- National Key Research and Development Program of China
- National Natural Science Foundation of China
Cite
APA
Zhou, X., Luo, M., Dai, G., Han, X., Yang, F., Qi, C., Jin, X., Lu, M., Wei, L., Zhu, S., Wang, H., & Xu, D. (2025). Disrupted Cholesterol Homeostasis as a Mechanism of Pharmaceutical-Induced Neurodevelopmental Toxicity: A Transgenic Zebrafish Screening Model for abcg1. Environmental Science & Technology. https://doi.org/10.1021/acs.est.5c04496
Vancouver
Zhou X, Luo M, Dai G, Han X, Yang F, Qi C, et al. Disrupted Cholesterol Homeostasis as a Mechanism of Pharmaceutical-Induced Neurodevelopmental Toxicity: A Transgenic Zebrafish Screening Model for abcg1. Environmental Science & Technology. 2025. doi:10.1021/acs.est.5c04496
BibTeX
@article{Zhou2025,
author = {Zhou, Xinli and Luo, Mingcui and Dai, Gaole and Han, Xiaoyi and Yang, Fang and Qi, Cuiping and Jin, Xiuping and Lu, Mengxi and Wei, Liyi and Zhu, Sen and Wang, Hui and Xu, Dan},
title = {Disrupted Cholesterol Homeostasis as a Mechanism of Pharmaceutical-Induced Neurodevelopmental Toxicity: A Transgenic Zebrafish Screening Model for abcg1},
journal = {Environmental Science & Technology},
year = {2025},
doi = {10.1021/acs.est.5c04496}
}
EUVIMED